These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 2106739)
1. Orthoclone OKT3 as first-line therapy in acute renal allograft rejection. Strate M; Jørgensen KA; Rohr N; Elbirk A; Svendsen V; Birkeland SA Transplant Proc; 1990 Feb; 22(1):219-20. PubMed ID: 2106739 [No Abstract] [Full Text] [Related]
2. Orthoclone OKT3 as rescue treatment for steroid-resistant and recurrent acute rejection in clinical renal transplantation. Tvedegaard E; Olgaard K Transplant Proc; 1990 Feb; 22(1):217-8. PubMed ID: 2106738 [No Abstract] [Full Text] [Related]
3. Use of Orthoclone OKT3 as treatment of acute renal allograft rejection and as first-line therapy in kidney transplantation. Winde G; Dietl KH; Raidt H; Buchholz B; Lison AE; Bünte H Transplant Proc; 1988 Oct; 20(5 Suppl 6):87-9. PubMed ID: 3140453 [No Abstract] [Full Text] [Related]
4. Acute renal allograft rejection: the role of monoclonal antibodies in treatment: experience with orthoclonal anti-T3 cell antibody. McLigeyo SO; Notghi A; Anderton JL; Dick J East Afr Med J; 1990 Sep; 67(9):667-73. PubMed ID: 2123786 [TBL] [Abstract][Full Text] [Related]
5. First and second course of OKT3 monoclonal anti-T cell antibody for treatment of renal allograft rejection followed by testing for anti-OKT3 IgM and/or IgG immunization. Birkeland SA; Bach JF; Chatenoud L; Jørgensen KA; Strate M; Elbirk A; Rohr N; Svendsen V Transplant Proc; 1990 Feb; 22(1):221-2. PubMed ID: 2106740 [No Abstract] [Full Text] [Related]
10. The treatment of steroid-resistant renal allograft rejection with OKT3 and plasmapheresis. Haberal M; Sert S; Gülay H; Arslan G; Bilgin N Transplant Proc; 1990 Aug; 22(4):1761-3. PubMed ID: 2117801 [No Abstract] [Full Text] [Related]
12. The effect of induction ALG (MALG) on the outcome of steroid-resistant rejection treated with OKT3 in renal transplant patients. Chiu A; Landsberg D; Cameron EC; Manson AD; Shackleton C Transplant Proc; 1991 Feb; 23(1 Pt 2):1039-40. PubMed ID: 1899146 [No Abstract] [Full Text] [Related]
13. Uses of orthoclone OKT3 for prophylaxis of rejection and induction in initial nonfunction in kidney transplantation. Kahana L; Ackermann J; Lefor W; Weinstein S; Wright C; DeQuesada A; Alveranga D; Baxter J; Shires D Transplant Proc; 1990 Aug; 22(4):1755-8. PubMed ID: 2117799 [TBL] [Abstract][Full Text] [Related]
14. The reuse of OKT3 after previous rejection or induction therapy in cadaveric renal transplantation. Shield CF; Hughes JD Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):35-8. PubMed ID: 2510509 [TBL] [Abstract][Full Text] [Related]
15. OKT3 prophylaxis versus conventional drug therapy: single-center perspective, part of a multicenter trial. Kahana L; Narvarte J; Ackermann J; LeFor W; Weinstein S; Wright C; deQuesada A; Baxter J; Shires D Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):5-9. PubMed ID: 2510510 [TBL] [Abstract][Full Text] [Related]
16. [Neurologic complications induced by the treatment of the acute renal allograft rejection with the monoclonal antibody OKT3]. Fernández O; Romero F; Bravo M; Burgos D; Cabello M; González-Molina M Neurologia; 1993 Oct; 8(8):277-80. PubMed ID: 8240843 [TBL] [Abstract][Full Text] [Related]
17. Comparison between prophylactic use of OKT3 and cyclosporine in cadaveric renal transplantation. De Pauw L; Abramowicz D; Goldman M; Vereerstraeten P; Kinnaert P; Toussaint C Transplant Proc; 1990 Aug; 22(4):1759-60. PubMed ID: 2117800 [No Abstract] [Full Text] [Related]
18. Safety and patient satisfaction with outpatient-administered OKT3 in combined kidney/pancreaticoduodenal allograft recipients. Overman JA; Perkins JD Transplant Proc; 1990 Apr; 22(2):681-2. PubMed ID: 2109389 [No Abstract] [Full Text] [Related]